Zhe Zheng

Zhe Zheng practices at Ochsner Medical Center - Baton Rouge in Baton Rouge, Louisiana, part of Ochsner Health System.

Zhe Zheng's NPI, 1083879175, was assigned on July 28, 2008. Zhe Zheng holds Louisiana license MD.206896.

Zhe Zheng's primary practice is Ochsner Medical Center - Baton Rouge, at 17000 Medical Center Dr, Baton Rouge, LA 70816 in E. Baton Rouge Parish. The practice phone is (225) 752-2470.

Zhe Zheng's primary practice is Ochsner Medical Center - Baton Rouge in Baton Rouge, Louisiana, part of Ochsner Health System. Zhe Zheng is also affiliated with Baton Rouge General - Bluebonnet. The medical group on file is Ochsner Health. Dmand AI also links Zhe Zheng to 1 more hospital and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Zhe Zheng practices, 4 sites in all. Vendor and product names are available with a free account.

Cardiovascular disease is Zhe Zheng's primary specialty in the NPI Registry, under taxonomy code 207RC0000X. Dmand AI has Zhe Zheng's licenses on file in 2 states: Louisiana and Massachusetts.

CMS data shows 2,292 Medicare services from Zhe Zheng across 23 procedure codes in 2024, for 1,193 Medicare patients. Medicare paid $98,974 for them.

CMS counts 1,193 Medicare patients who saw Zhe Zheng in 2024. The largest group is 65 to 74, with 536 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 16% are also on Medicaid. Their average risk score is 1.94, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Zhe Zheng's median patient age at 73, with 57% women.

In 2024, Zhe Zheng wrote 15,138 Medicare Part D claims for 1,741 patients. 79% of them were for generic drugs. CMS names the drug for 14,902 of them, across 78 drugs with 11 or more claims each, at $2,262,839 in total drug cost. In 2023, CMS named 12,446 claims across 70 drugs.

Zhe Zheng accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Zhe Zheng as offering telehealth.

Dmand AI links 23 papers to Zhe Zheng, published from 2014 to 2025. 2022 was the busiest year, with 6. The most frequent topics are Respiratory Syncytial Virus Infections, Seasons and COVID-19. Zhe Zheng has published most often in Adv Sci (Weinh). Zhe Zheng's most frequent co-authors are Eugene D. Shapiro, MD, John H. Alexander and Grace L. Chen, MD, MPH.

CMS Open Payments shows 62 general payments to Zhe Zheng from 18 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 75% of the total. Abbott Laboratories paid the most, $1,875.